FAC Explorer

Audit 339886

FY End
2024-06-30
Total Expended
$5.43M
Findings
0
Programs
24
Organization: Berkshire Regional Planning Commission (MA)
Year: 2024 Accepted: 2025-01-27
Auditor: Adelson & Company PC

Organization Exclusion Status:

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
66.818 Brownfields Multipurpose, Assessment, Revolving Loan Fund, and Cleanup Cooperative Agreements $2.44M Yes 0
20.505 Metropolitan Transportation Planning and State and Non-Metropolitan Planning and Research $499,017 - 0
93.279 Drug Abuse and Addiction Research Programs $379,244 - 0
93.354 Public Health Emergency Response: Cooperative Agreement for Emergency Response: Public Health Crisis Response $210,655 - 0
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $189,452 - 0
21.019 Coronavirus Relief Fund $182,850 - 0
10.177 Regional Food System Partnerships $170,504 - 0
93.069 Public Health Emergency Preparedness $167,496 - 0
93.959 Block Grants for Prevention and Treatment of Substance Abuse $164,090 - 0
93.788 Opioid Str $98,925 - 0
93.048 Special Programs for the Aging, Title Iv, and Title Ii, Discretionary Projects $87,485 - 0
95.007 Research and Data Analysis $80,224 - 0
66.605 Performance Partnership Grants $79,618 - 0
11.302 Economic Development Support for Planning Organizations $69,998 - 0
20.939 Safe Streets and Roads for All $65,537 - 0
21.027 Coronavirus State and Local Fiscal Recovery Funds $29,098 - 0
66.034 Surveys, Studies, Research, Investigations, Demonstrations, and Special Purpose Activities Relating to the Clean Air Act $28,983 - 0
11.307 Economic Adjustment Assistance $28,605 - 0
11.035 Broadband Equity, Access, and Deployment Program $13,688 - 0
45.024 Promotion of the Arts Grants to Organizations and Individuals $12,673 - 0
93.391 Activities to Support State, Tribal, Local and Territorial (stlt) Health Department Response to Public Health Or Healthcare Crises $12,276 - 0
66.110 Healthy Communities Grant Program $8,790 - 0
16.838 Comprehensive Opioid, Stimulant, and Other Substances Use Program $8,487 - 0
93.103 Food and Drug Administration Research $1,580 - 0

Contacts

Name Title Type
GFGWCNA65QH6 Thomas Matuszko Auditee
4134421521 David M. Irwin, CPA Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.